The short answer: GHK-Cu dosage is individualised - most clinical and research protocols use 0.52 mg per day subcutaneously, but many patients do not inject every day at all
It may also help older patients who want to maintain joint function and daily mobility

Contact your healthcare provider if you experience: Hot flashes accompanied by chest pain, palpitations, or irregular heartbeat Severe or persistent flushing with associated shortness of breath or dizziness Hot flashes that significantly interfere with daily activities or sleep quality New or worsening symptoms despite lifestyle modifications Severe, persistent abdominal pain (especially radiating to the back) with or without vomiting Yellowing of skin/eyes (jaundice), pale stools, or dark urine Signs of allergic reaction including facial/lip swelling, rash, hives, or difficulty breathing Signs of thyroid dysfunction including tremor, anxiety, or changes in bowel habits Concurrent symptoms such as excessive sweating, fever, or night sweats If you're taking tirzepatide with insulin or sulfonylureas, check your blood glucose during episodes that resemble hot flashes, as hypoglycemia can cause similar symptoms
When you come off, you're not fighting metabolic adaptation as severely
Is BPC-157 TB-500 10mg peptide legal in the UK